Cell therapy bioprocessing and analytics: today’s key tools and innovation requirements to meet future demand

Cell & Gene Therapy Insights 2020; 6(10), 1527–1528

10.18609/cgti.2020.167

Published: 1 December 2020
Foreword
John Paul Tomtishen III

John Paul Tomtishen III is currently employed by Legend Biotech where he serves as the Site Managing Director of Legend’s corporate headquarters in Somerset, NJ and is responsible for Legend’s back office functions, including Engineering/Facilities and Sourcing/Procurement. John also has oversight over Legend’s US Manufacturing and Technical Operations teams and is responsible for developing robust global CMC strategies to ensure best-in-class, end-to-end manufacturing and supply chain capabilities for Legend’s cell and gene therapy product portfolio.